Amyloid-associated depression: a prodromal depression of Alzheimer disease?
- PMID: 18458206
- PMCID: PMC3042807
- DOI: 10.1001/archpsyc.65.5.542
Amyloid-associated depression: a prodromal depression of Alzheimer disease?
Abstract
Context: A high ratio of plasma amyloid-beta peptide 40 (Abeta(40)) to Abeta(42), determined by both high Abeta(40) and low Abeta(42) levels, increases the risk of Alzheimer disease. In a previous study, we reported that depression is also associated with low plasma Abeta(42) levels in the elderly population.
Objective: To characterize plasma Abeta(40):Abeta(42) ratio and cognitive function in elderly individuals with and without depression.
Design: Cross-sectional study.
Setting: Homecare agencies.
Participants: A total of 995 homebound elderly individuals of whom 348 were defined as depressed by a Center for Epidemiological Studies Depression score of 16 or greater.
Main outcome measures: Cognitive domains of memory, language, executive, and visuospatial functions according to levels of plasma Abeta(40) and Abeta(42) peptides.
Results: Subjects with depression had lower plasma Abeta(42) levels (median, 14.1 vs 19.2 pg/mL; P = .006) and a higher plasma Abeta(40):Abeta(42) ratio (median, 8.9 vs 6.4; P < .001) than did those without depression in the absence of cardiovascular disease and antidepressant use. The interaction between depression and plasma Abeta(40):Abeta(42) ratio was associated with lower memory score (beta = -1.9, SE = 0.7, P = .006) after adjusting for potentially confounders. Relative to those without depression, "amyloid-associated depression," defined by presence of depression and a high plasma Abeta(40):Abeta(42) ratio, was associated with greater impairment in memory, visuospatial ability, and executive function; in contrast, nonamyloid depression was not associated with memory impairment but with other cognitive disabilities.
Conclusion: Amyloid-associated depression may define a subtype of depression representing a prodromal manifestation of Alzheimer disease.
Figures

Similar articles
-
Serum beta-amyloid correlates with neuropsychological impairment.Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009 Mar;16(2):203-18. doi: 10.1080/13825580802411766. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2009. PMID: 18923961
-
Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):238-44. doi: 10.1097/WAD.0b013e31819cb3ac. Alzheimer Dis Assoc Disord. 2009. PMID: 19812466 Free PMC article.
-
Different Sides of Depression in the Elderly: An In-depth View on the Role of Aβ Peptides.Curr Med Chem. 2022;29(36):5731-5757. doi: 10.2174/0929867328666210921164816. Curr Med Chem. 2022. PMID: 34547994
-
Serum Levels of Albumin-β-Amyloid Complex in Patients with Depression.Am J Geriatr Psychiatry. 2016 Sep;24(9):764-72. doi: 10.1016/j.jagp.2016.05.005. Epub 2016 May 18. Am J Geriatr Psychiatry. 2016. PMID: 27401050
-
Is plasma amyloid-beta a reliable biomarker for Alzheimer's disease?Recent Pat CNS Drug Discov. 2008 Jun;3(2):109-11. doi: 10.2174/157488908784534595. Recent Pat CNS Drug Discov. 2008. PMID: 18537770 Review.
Cited by
-
Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer's Disease.Front Genet. 2021 Dec 9;12:722221. doi: 10.3389/fgene.2021.722221. eCollection 2021. Front Genet. 2021. PMID: 34956307 Free PMC article.
-
Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.Mol Psychiatry. 2015 Feb;20(2):252-62. doi: 10.1038/mp.2014.17. Epub 2014 Mar 11. Mol Psychiatry. 2015. PMID: 24614496 Free PMC article.
-
Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis.J Psychiatr Res. 2015 Oct;69:35-41. doi: 10.1016/j.jpsychires.2015.07.024. Epub 2015 Jul 26. J Psychiatr Res. 2015. PMID: 26343592 Free PMC article.
-
Plasma beta amyloid level and depression in older adults.J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):74-9. doi: 10.1093/gerona/gls093. Epub 2012 Apr 12. J Gerontol A Biol Sci Med Sci. 2013. PMID: 22499763 Free PMC article.
-
The Effectiveness of Training Programs on the Fidelity of Neuropsychological Tests.Yonago Acta Med. 2019 Oct 25;62(4):278-284. doi: 10.33160/yam.2019.11.003. eCollection 2019 Dec. Yonago Acta Med. 2019. PMID: 31849567 Free PMC article.
References
-
- van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM. Plasma Aβ1–40 and Aβ1–40 and the risk of dementia: a prospective case-cohort study. Lancet Neurol. 2006;5(8):655–660. - PubMed
-
- Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG. Association of low plasma Aβ42/Aβ40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease [published correction appears in Arch Neurol. 2007;64(9):1246] Arch Neurol. 2007;64(3):354–362. - PubMed
-
- Qiu WQ, Sun X, Selkoe DJ, Mwamburi DM, Huang T, Bhadela R, Bergethon P, Scott TM, Summergrad P, Wang L, Rosenberg I, Folstein M. Depression is associated with low plasma Aβ42 independently of cardiovascular disease in the homebound elderly. Int J Geriatr Psychiatry. 2007;22(6):536–542. - PubMed
-
- Iwatsubo T. Amyloid beta protein in plasma as a diagnostic marker for Alzheimer’s disease. Neurobiol Aging. 1998;19(2):161–163. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical